Priya Karmali

Priya Karmali

Company: Capstan Therapeutics

Job title: Chief Technology Officer


In Vivo Engineering of Cells Using Targeted Lipid Nanoparticles 2:45 pm

Capstan’s novel targeted LNP (tLNP) platform purpose-built for preferential delivery of RNA to target cells tLNP platform enables two distinct approaches in vivo: direct engineering of immune cells and targeting pathogenic cells Versatility of this non-viral, redosable and scalable platform allows for in vivo RNA-based therapies across broad range of diseasesRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.